Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

85.62
Delayed Data
As of Oct 20
 -0.09 / -0.11%
Today’s Change
53.15
Today|||52-Week Range
88.98
+44.65%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+0.57% 3 years+17.87%
3 months+6.79% 5 years+24.03%
1 year+43.23% Since inception+15.49%
Data through 10/21/2017

Quote Details

Previous close$85.71
Open day’s range84.72 – 85.94
Net asset value (NAV)85.62 (10/20/2017)
Daily volume5,151,715
Average volume (3 months)3,859,989
Data as of 7:59pm ET, 10/20/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+24.03%+16.79%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.821.10
Net assets$4.1B$3.1B
Average market cap$4.7B$30.9B
Average P/E--26.2
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ALNY Alnylam Pharmaceuticals Inc2.91%
CLVS Clovis Oncology Inc2.24%
PBYI Puma Biotechnology Inc2.10%
EXAS Exact Sciences Corp2.03%
BLUE bluebird bio Inc2.01%
TSRO TESARO Inc1.96%
JUNO Juno Therapeutics Inc1.96%
NBIX Neurocrine Biosciences Inc1.94%
SRPT Sarepta Therapeutics Inc1.93%
AVXS AveXis Inc1.90%